PEAK6 Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-6,100
Closed -$103K 4270
2016
Q1
$103K Buy
+6,100
New +$107K ﹤0.01% 3577
2015
Q3
Sell
-11,000
Closed -$271K 5102
2015
Q2
$271K Hold
11,000
﹤0.01% 3427
2015
Q1
$225K Buy
+11,000
New +$213K ﹤0.01% 3349
2014
Q2
Sell
-10,700
Closed -$201K 4598
2014
Q1
$201K Buy
+10,700
New +$219K ﹤0.01% 3425

Other funds holding ATRC

PEAK6 Group's ATRC Position: Q2 2016 in Review

PEAK6 Group sold out of AtriCure (ATRC) in Q2 2016, closing a stake of 1,789 shares — an estimated $30K sold.

PEAK6 Group first reported a position in ATRC in Q2 2013 and held it in 2 quarters. The position peaked at $30K in Q1 2016. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

  • PEAK6 Group reported no remaining AtriCure position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 1,789 AtriCure shares in Q2 2016, an estimated $30K.
  • PEAK6 Group first reported a position in AtriCure in Q2 2013 and held it in 2 quarters.
  • PEAK6 Group's AtriCure position peaked at $30K in Q1 2016.
  • 102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.